PHLT 8331 Week 2 Variable Distribution Brief Example

Course	PHLT 8331 Fundamentals of Biostatistics
Week	Week 2
Paper type	Distribution brief
Length	About 720 words, 5 pages
Format	APA 7 student paper
School	Walden University
Program	PhD in Public Health
Updated	October 2026

Free sample paper for PHLT 8331 Week 2

Shape Before Any Test: A Distribution Brief on Four Variables in a Composite Anticoagulation Registry and What Each Shape Allows in the Weeks Ahead

Student Name

Walden University

PHLT 8331: Fundamentals of Biostatistics

Instructor Name

Month Day, Year

What this page is doingThe title puts distribution ahead of testing, the order the brief argues for, and names the four variables whose shapes it describes.

Shape Before Any Test: A Distribution Brief on Four Variables in a Composite Anticoagulation Registry and What Each Shape Allows in the Weeks Ahead

Why Shape Comes First

Every procedure later in this course assumes something about the data it is applied to. A t-test assumes that sample means are approximately normally distributed, a chi-square test assumes enough expected counts in each cell, and a test for counts assumes something about how often events occur. This brief describes four variables in the composite anticoagulation registry, names the distribution each resembles and says what that resemblance allows and rules out. Figures are composite.

What this page is doingLinking shape to the assumptions of later tests explains why describing distributions is the first analytic step, not a formality.

Variable 1: Time in Therapeutic Range

Time in therapeutic range is the percentage of days a patient's INR was between 2.0 and 3.0 in a six-month period, estimated by interpolating between test dates (Rosendaal et al., 1993). It is bounded at 0 and 100, and in this registry it is skewed to the left: most patients fall between 50% and 90%, a long tail stretches toward low values and a cluster of well-controlled patients sits near 100%. The median is 67% and the mean 64%. The shape is not normal, but with hundreds of patients in each group, the sampling distribution of the mean will be close to normal, because the central limit theorem applies to means even when individual values are skewed. Lumley et al. (2002) showed that t-tests and regression perform well in large public health datasets even when outcomes are far from normal. The shape does rule out treating the mean as a typical value without also reporting the median.

Variable 2: Change in Time in Therapeutic Range

For the 212 patients whose warfarin care shifted to the pharmacist service, the change in time in therapeutic range between the six months before and after the move is roughly symmetric, centered near 8 percentage points, with a standard deviation of about 19. Change scores often look more normal than the measurements they come from, because subtracting two skewed values from the same patient can cancel some of the skew. This shape supports a paired t-test on the changes, which Week 4 will use.

Variable 3: Number of INR Tests

The number of INR tests in six months is a count, always a whole number and never negative. Its distribution is skewed to the right: most patients had between 6 and 14 tests, but some unstable patients had more than 25. Counts like this often resemble a Poisson distribution (Pagano et al., 2022), in which the variance equals the mean, but here the variance is about three times the mean, a pattern called overdispersion. That rules out methods assuming a Poisson shape without adjustment and argues for reporting medians and interquartile ranges when describing groups.

Variable 4: Good Control

Whether a patient's time in therapeutic range reached 65%, the registry's threshold for good control, is a binary variable: each patient either did or did not. Its distribution is Bernoulli, fully described by a single proportion, 59.6% among the 804 patients with a complete six-month period. A binary variable has no shape to check beyond that proportion, but describing it matters, because tests for proportions, such as the chi-square test in Week 7, require enough patients in each category for their approximations to hold.

What the Shapes Allow

Table 1

Four Variables, Their Shapes and What Each Shape Allows

Variable	Shape	Summarize with	Allows	Rules out \|
Time in therapeutic range	Left-skewed, bounded	Median and mean, both	Mean comparisons in large groups	Mean as typical value alone \|
Change in time in range	Roughly symmetric	Mean and standard deviation	Paired t-test	Nothing major \|
Number of INR tests	Right-skewed count, overdispersed	Median and interquartile range	Count methods allowing extra variance	Simple Poisson methods \|
Good control	Bernoulli	Proportion	Tests of proportions with adequate counts	Any test needing a continuous outcome \|

Note. Composite figures from the registry. The registry counts a patient as well controlled when at least 65% of the period falls inside the INR target.

A Note on Normality Tests

The brief does not report a formal normality test for each variable. With samples this large, such tests reject normality for trivial departures, and with small samples they miss large ones. Plots and the size of the sample are more informative (Lumley et al., 2002).

References

Lumley, T., Diehr, P., Emerson, S., & Chen, L. (2002). The importance of the normality assumption in large public health data sets. Annual Review of Public Health, 23, 151-169. https://doi.org/10.1146/annurev.publhealth.23.100901.140546

Pagano, M., Gauvreau, K., & Mattie, H. (2022). Principles of biostatistics (3rd ed.). CRC Press.

Rosendaal, F. R., Cannegieter, S. C., van der Meer, F. J. M., & Briët, E. (1993). A method to determine the optimal intensity of oral anticoagulant therapy. Thrombosis and Haemostasis, 69(3), 236-239. https://doi.org/10.1055/s-0038-1651587

What the PHLT 8331 Week 2 instructions ask for

The second week's brief typically asks students to describe the distributions of key variables in their dataset and explain the implications for later analysis. The expectation is that each variable's shape will be identified accurately, using summary statistics and plots, and linked to what it allows or rules out: which summaries to report, which tests are appropriate and which need caution. Continuous, count and binary variables raise different issues. Students should understand that many tests rely on the distribution of sample means rather than raw values. Briefs usually run two to three pages, often with a summary table, and cite a statistics text or methods paper.

How this PHLT 8331 Week 2 example is built

The brief opens by explaining why shape precedes testing. Four sections each describe one variable. Time in therapeutic range is described as bounded and left-skewed, with mean and median reported and the central limit theorem invoked, citing research on normality in large public health datasets and the interpolation method. Change scores are described as roughly symmetric and suited to a paired test. The INR test count is described as right-skewed with variance about three times the mean, citing a biostatistics text on Poisson distributions. Good control is described as Bernoulli. A table summarizes shape, summary statistics, what each allows and what it rules out, and a closing note explains the omission of normality tests.

Where the marks sit in the PHLT 8331 Week 2 rubric

Instructors look for accurate identification of each shape and a sound link to later methods. The sample earns credit for distinguishing the shape of raw values from the sampling distribution of the mean, a point central to this course. Recognizing overdispersion in the count variable shows attention beyond the obvious. Treating the binary variable as worth describing, and connecting it to later tests of proportions, demonstrates completeness. Accuracy is checked in the summary statistics and their interpretation. A clear table and correctly cited sources account for the presentation marks. Linking each shape to a specific later week's test shows the brief is planning ahead rather than describing for its own sake. Instructors also notice when the mean and median are both reported for a skewed outcome, since the gap between them is itself informative.

PHLT 8331 Week 2 help: mistakes that cost marks

A common slip in distribution briefs is listing a mean and standard deviation for each measure without checking its shape. Plot each variable first. For skewed data, report the median alongside the mean. Remember that many tests depend on the distribution of the mean, which approaches normality in large samples even when the data do not. For counts, check whether the variance is much larger than the mean. Do not skip binary variables; their proportions matter for later tests. Avoid relying on formal normality tests in very large or very small samples. A matching brief for your own variables is available free on request. Name the later test each shape affects, so the brief reads as a plan. Keep the descriptions short and let the table carry the detail.

Get a PHLT 8331 Week 2 example written to your instructions

Tell the desk which variables your section assigned, and add the Week 2 prompt and rubric. A distribution brief with a panel per variable, a sampling-distribution section and a summary table follows in 24-48h, and a first request carries no charge. Its plots describe a composite registry and cannot replace plotting your own variables.

More PHLT 8331 papers and PhD in Public Health samples

PHLT 8331 Week 2 questions, answered

Where can I find a free PHLT 8331 Week 2 sample paper?

You can read the whole Week 2 distribution brief here, describing four variables in a composite anticoagulation registry and what each shape allows, with a summary table and cited sources.

Does the normality condition apply to the raw data or to the mean?

For t-tests and related methods, the condition applies to the sampling distribution of the mean. With large samples, that distribution is approximately normal even when individual values are skewed, which is why the sample treats a skewed outcome as acceptable for mean comparisons.

What is overdispersion?

It is when a count variable's variance is larger than its mean, which a Poisson distribution assumes are equal. The sample's INR test counts have variance about three times the mean, so methods that assume Poisson variation would understate uncertainty.

Should the brief report a normality test for each variable?

Not necessarily. In large samples, formal tests reject normality for trivial departures, and in small samples they miss large ones. Plots and attention to sample size are usually more informative.

Why describe a binary variable's distribution?

Because its single proportion determines how much information it carries and whether tests of proportions will have enough patients in each category. The sample reports that 59.6% of patients had good control.